Table 2.

Individual NPSLE manifestations in 72 SLE patients

NPSLE-manifestation	SLICC A model	SLICC B model	ACR model
Any NPSLE-manifestation, n (%)	16 (22%)	23 (32%)	44 (61%)
Cognitive dysfunction, n (%)	0 (0%)	5 (7%)	26 (36%)
Headache, n (%)	N/A	N/A	22 (31%)
Depression, n (%)	0 (0%)	1 (1%)	13 (18%)
Anxiety disorder, n (%)	N/A	N/A	12 (17%)
Autonomic neuropathy, n (%)	7 (10%)	8 (11%)	10 (14%)
Cranial neuropathy, n (%)	7 (10%)	7 (10%)	7 (10%)
Cerebrovascular disease, n (%)	1 (1%)	5 (7%)	5 (7%)
Demyelinating disease, n (%)	3 (4%)	3 (4%)	3 (4%)
Myelopathy, n (%)	2 (3%)	3 (4%)	3 (4%)
Acute confusional state, n (%)	1 (1%)	2 (3%)	3 (4%)
Polyneuropathy, n (%)	1 (1%)	1 (1%)	3 (4%)
Seizures, n (%)	1 (1%)	2 (3%)	2 (3%)
Mononeuritis, n (%)	1 (1%)	2 (3%)	2 (3%)
Aseptic meningitis, n (%)	1 (1%)	1 (1%)	1 (1%)
Psychosis, n (%)	1 (1%)	1 (1%)	1 (1%)
Chorea, n (%)	0 (0%)	1 (1%)	1 (1%)
Guillain-Barré syndrome, n (%)	0 (0%)	0 (0%)	0 (0%)
Plexopathy, n (%)	0 (0%)	0 (0%)	0 (0%)
Myasthenia gravis, n (%)	0 (0%)	0 (0%)	0 (0%)

One patient may have more than one NPSLE-manifestation

NPSLE Neuropsychiatric Systemic Lupus Erythematosus, SLICC Systemic Lupus Erythematosus International Collaborating Clinics, ACR American College of Rheumatology, N/A Not applicable